Anti-FAM47E monoclonal antibody

Pre-made anti-FAM47E monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM47E/FAM47E products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2489-Ab-1/ GM-Tg-hg-IP2489-Ab-2Anti-Human FAM47E monoclonal antibodyHuman
GM-Tg-rg-IP2489-Ab-1/ GM-Tg-rg-IP2489-Ab-2Anti-Rat FAM47E monoclonal antibodyRat
GM-Tg-mg-IP2489-Ab-1/ GM-Tg-mg-IP2489-Ab-2Anti-Mouse FAM47E monoclonal antibodyMouse
GM-Tg-cynog-IP2489-Ab-1/ GM-Tg-cynog-IP2489-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM47E monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2489-Ab-1/ GM-Tg-felg-IP2489-Ab-2Anti-Feline FAM47E monoclonal antibodyFeline
GM-Tg-cang-IP2489-Ab-1/ GM-Tg-cang-IP2489-Ab-2Anti-Canine FAM47E monoclonal antibodyCanine
GM-Tg-bovg-IP2489-Ab-1/ GM-Tg-bovg-IP2489-Ab-2Anti-Bovine FAM47E monoclonal antibodyBovine
GM-Tg-equg-IP2489-Ab-1/ GM-Tg-equg-IP2489-Ab-2Anti-Equine FAM47E monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2489-Ab-1/ GM-Tg-hg-IP2489-Ab-2; GM-Tg-rg-IP2489-Ab-1/ GM-Tg-rg-IP2489-Ab-2;
GM-Tg-mg-IP2489-Ab-1/ GM-Tg-mg-IP2489-Ab-2; GM-Tg-cynog-IP2489-Ab-1/ GM-Tg-cynog-IP2489-Ab-2;
GM-Tg-felg-IP2489-Ab-1/ GM-Tg-felg-IP2489-Ab-2; GM-Tg-cang-IP2489-Ab-1/ GM-Tg-cang-IP2489-Ab-2;
GM-Tg-bovg-IP2489-Ab-1/ GM-Tg-bovg-IP2489-Ab-2; GM-Tg-equg-IP2489-Ab-1/ GM-Tg-equg-IP2489-Ab-2
Products NameAnti-FAM47E monoclonal antibody
Formatmab
Target NameFAM47E
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM47E monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2489-Ag-1Recombinant multi-species FA47E/ FAM47E protein


    Target information

    Target IDGM-IP2489
    Target NameFAM47E
    Gene ID100129583,384198,686140,699865,101091365,508540
    Gene Symbol and SynonymsC730043O17,FAM47E,Fam47e-ps1,Gm1381
    Uniprot AccessionQ6ZV65
    Uniprot Entry NameFA47E_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000189157
    Target ClassificationN/A

    The target: FAM47E, gene name: FAM47E, also named as . Enables enzyme activator activity. Involved in positive regulation of histone methylation and protein localization to chromatin. Located in chromatin; cytoplasm; and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.